E01. Girda E; Phaeton R; Nevadunsky N; Huang G; Smith Ho; Smotkin D; Goldberg G; Kuo D, 2013(11 Girda E, Phaeton R, Goldberg GL, Kuo D. Extending the interval for port-a-cath maintenance. Modern Chemother. 2013 Oct;2(2):15-8. doi: 10.4236/mc.2013.22003 https://doi.org/10.4236/mc.2013.22003...
). |
Extending the interval for port-a-cath maintenance |
2B
|
Categoria A
|
E02. Dal Molin A, Clerico M, Baccini M, Guerretta L, Sartorello B, Rasero L, 2015(2222 Dal Molin A, Clerico M, Baccini M, Guerretta L, Sartorello B, Rasero L. Normal saline versus heparin solution to lock totally implanted venous access devices: results from a multicenter randomized trial. Eur J Oncol Nurs. [Internet]. 2015[cited Oct 10, 2018];19(6):638-43. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25933709
https://www.ncbi.nlm.nih.gov/pubmed/2593...
). |
Normal saline versus heparin solution to lock totally implanted venous access devices: Results from a multicenter randomized trial |
1B
|
Alta qualidade |
E03. Brito, 2018(2323 Brito ARO, Nishinari K, Saad PF, Saad KR, Pereira MAT, Emídio SCD, et al. Comparison between saline solution containing heparin versus saline solution in the lock of totally implantable catheters. Ann Vasc Surg. [Internet]. 2018 Feb[cited Aug 03, 2018];47:85-9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28947219
https://www.ncbi.nlm.nih.gov/pubmed/2894...
). |
Comparison between Saline Solution Containing Heparin versus Saline Solution in the Lock of Totally Implantable Catheters |
2B
|
Categoria A
|
E04. Goossens GA; Jérôme M; Janssens C; Peetermans WE; Fieuws S; Moons P; Verschakelen J; Peerlinck K; Jacquemin M; Stas M, 2013(2424 Goossens GA. Flushing and locking of venous catheters: available evidence and evidence deficit. Nurs Res Pract. [Internet]. 2015 [cited Oct 10, 2018];2015:985686. Available from: https://www.hindawi.com/journals/nrp/2015/985686
https://www.hindawi.com/journals/nrp/201...
). |
Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial |
1B
|
Alta qualidade |
E05. Bertoglio S, Solari N, Meszaros P, Vassallo F, Bonvento M, Pastorino S, Bruzzi P, 2012(2525 Bertoglio S, Solari N, Meszaros P, Vassallo F, Bonvento M, Pastorino S, et al. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Cancer Nurs. [Internet]. 2012 Jul-Ago[cited Aug 03, 2018];35(4):E35-42. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22228390
https://www.ncbi.nlm.nih.gov/pubmed/2222...
). |
Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients |
2B
|
Categoria A
|
E06.Kuo YS; Schwartz B; Santiago J; Anderson PS; Fields AL; Goldberg GL, 2005(2626 Kuo YS, Schwartz B, J Santiago, Anderson PS, Campos AL, Goldberg GL. How often should a port-A-cath be flushed? Cancer Invest. [Internet]. 2005 [cited Nov 05, 2018];23(7):582-5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16305984
https://www.ncbi.nlm.nih.gov/pubmed/1630...
). |
How Often Should a Port-A-Cath be Flushed? |
2B
|
Categoria B
|
E07. Baram A, Majeed G, Abdullah H, Subhi A, 2014(2727 Baram A, Majeed G, Abdullah H, Subhi A. Heparin versus saline solution for locking of totally implantable venous access port (TIVAP): cohort study of the first Kurdistan series of TIVAP. Adv Lung Cancer. [Internet]. Dec 2014 [cited Aug 03, 2018];3(4):67-74. Available from: https://www.scirp.org/journal/PaperInformation.aspx?PaperID=51365
https://www.scirp.org/journal/PaperInfor...
). |
Heparin versus Saline Solution for Locking of Totally Implantable Venous Access Port (TIVAP): Cohort Study of the First Kurdistan Series of TIVAP |
2B
|
Categoria A
|
E08. Goossens GA, 2014(2828 Goossens GA, Jérôme M, Janssens C, Peetermans WE, Fieuws S, Moons P, et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Ann Oncol. [Internet]. 2013 Jul [cited Nov 05, 2018];24(7):1892-9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23553060
https://www.ncbi.nlm.nih.gov/pubmed/2355...
). |
Flushing and Locking of Venous Catheters: Available Evidence and Evidence Deficit |
1A
|
Média qualidade |
E09. López-Briz E, Ruiz GV, Cabello JB, Bort-Marti S, Carbonell SR, Burls A, 2014(2929 López-Briz E, Ruiz GV, Cabello JB, Bort-Marti S, Carbonell SR, Burls A. Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults. Cochrane Database Syst Rev. [Internet]. 2014 Oct [cited Aug 03, 2018];(10):CD008462. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25300172
https://www.ncbi.nlm.nih.gov/pubmed/2530...
). |
Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults |
1A
|
Alta qualidade |
E10. Palese A, Baldassar D, Rupil A et al. 2014(33 Palese A, Baldassar D, Rupil A, Bonanni G, Capellari Maria T, Contessi D, et al. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals. Eur J Oncol Nurs. 2014 Feb;18(1):66-71. doi: 10.1016/j.ejon.2013.09.002 https://doi.org/10.1016/j.ejon.2013.09.0...
). |
Maintaining patency in totally implantable venous access devices (TIVAD): A time-to-event analysis of different lock irrigation intervals |
2B
|
Categoria A
|
E11. Johansson E, Björkholm M, Björvell H et al 2004(3030 Johansson E, Björkholm H, Björvell H, Acaso R, Takolander R, Olofsson P, et al. Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia - a randomized study. Support Care Cancer. [Internet]. 2004 Feb [cited Oct 03, 2018];12(2):99-105. Available from: https://www.ncbi.nlm.nih.gov/pubmed/14648310
https://www.ncbi.nlm.nih.gov/pubmed/1464...
). |
Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia-a randomized study |
1B
|
Alta qualidade |
E12. Kefeli U, Dane F, Yumuk PF, et al 2009(3131 Kefeli U, Dane F, Yumuk PF, Karamanoglu A, Iyikesici S, Basaran G, et al. Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer. Eur J Cancer Care. [Internet]. 2009 Mar [cited Oct 10, 2018];18(2):191-4. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19267736
https://www.ncbi.nlm.nih.gov/pubmed/1926...
). |
Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer |
2B
|
Categoria A
|
E13. Biffi R, Braud F, Orsi F et al 2001(3232 Biffi R, De Braud F, Orsi F, Pozzi S, Arnaldi P, Rotmensz N, et al. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer. [Internet]. 2001 Sep [cited Aug 03, 2018];1;92(5):1204-12. Available from: https://www.ncbi.nlm.nih.gov/pubmed/11571734
https://www.ncbi.nlm.nih.gov/pubmed/1157...
). |
A randomized, prospective trial of central venous ports connected to standard openended or Groshong catheters in adult oncology patients |
1B
|
Alta qualidade |